191 related articles for article (PubMed ID: 17489740)
1. Identification of a novel 82 kDa proMMP-9 species associated with the surface of leukaemic cells: (auto-)catalytic activation and resistance to inhibition by TIMP-1.
Ries C; Pitsch T; Mentele R; Zahler S; Egea V; Nagase H; Jochum M
Biochem J; 2007 Aug; 405(3):547-58. PubMed ID: 17489740
[TBL] [Abstract][Full Text] [Related]
2. Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells.
Morodomi T; Ogata Y; Sasaguri Y; Morimatsu M; Nagase H
Biochem J; 1992 Jul; 285 ( Pt 2)(Pt 2):603-11. PubMed ID: 1379048
[TBL] [Abstract][Full Text] [Related]
3. Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis.
Ardi VC; Kupriyanova TA; Deryugina EI; Quigley JP
Proc Natl Acad Sci U S A; 2007 Dec; 104(51):20262-7. PubMed ID: 18077379
[TBL] [Abstract][Full Text] [Related]
4. TIMP-1 binding to proMMP-9/CD44 complex localized at the cell surface promotes erythroid cell survival.
Lambert E; Bridoux L; Devy J; Dassé E; Sowa ML; Duca L; Hornebeck W; Martiny L; Petitfrère-Charpentier E
Int J Biochem Cell Biol; 2009 May; 41(5):1102-15. PubMed ID: 19010442
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil MMP-9 proenzyme, unencumbered by TIMP-1, undergoes efficient activation in vivo and catalytically induces angiogenesis via a basic fibroblast growth factor (FGF-2)/FGFR-2 pathway.
Ardi VC; Van den Steen PE; Opdenakker G; Schweighofer B; Deryugina EI; Quigley JP
J Biol Chem; 2009 Sep; 284(38):25854-66. PubMed ID: 19608737
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties.
Okada Y; Gonoji Y; Naka K; Tomita K; Nakanishi I; Iwata K; Yamashita K; Hayakawa T
J Biol Chem; 1992 Oct; 267(30):21712-9. PubMed ID: 1400481
[TBL] [Abstract][Full Text] [Related]
7. Circular trimers of gelatinase B/matrix metalloproteinase-9 constitute a distinct population of functional enzyme molecules differentially regulated by tissue inhibitor of metalloproteinases-1.
Vandooren J; Born B; Solomonov I; Zajac E; Saldova R; Senske M; Ugarte-Berzal E; Martens E; Van den Steen PE; Van Damme J; Garcia-Pardo A; Froeyen M; Deryugina EI; Quigley JP; Moestrup SK; Rudd PM; Sagi I; Opdenakker G
Biochem J; 2015 Jan; 465(2):259-70. PubMed ID: 25360794
[TBL] [Abstract][Full Text] [Related]
8. Activation of MMP-9 by membrane type-1 MMP/MMP-2 axis stimulates tumor metastasis.
Li Z; Takino T; Endo Y; Sato H
Cancer Sci; 2017 Mar; 108(3):347-353. PubMed ID: 27987367
[TBL] [Abstract][Full Text] [Related]
9. Peptide from the C-terminal domain of tissue inhibitor of matrix metalloproteinases-2 (TIMP-2) inhibits membrane activation of matrix metalloproteinase-2 (MMP-2).
Xu X; Mikhailova M; Chen Z; Pal S; Robichaud TK; Lafer EM; Baber S; Steffensen B
Matrix Biol; 2011 Sep; 30(7-8):404-12. PubMed ID: 21839835
[TBL] [Abstract][Full Text] [Related]
10. Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases.
Sato T; Sakai T; Noguchi Y; Takita M; Hirakawa S; Ito A
Gynecol Oncol; 2004 Jan; 92(1):47-56. PubMed ID: 14751137
[TBL] [Abstract][Full Text] [Related]
11. Angiogenic capacity of M1- and M2-polarized macrophages is determined by the levels of TIMP-1 complexed with their secreted proMMP-9.
Zajac E; Schweighofer B; Kupriyanova TA; Juncker-Jensen A; Minder P; Quigley JP; Deryugina EI
Blood; 2013 Dec; 122(25):4054-67. PubMed ID: 24174628
[TBL] [Abstract][Full Text] [Related]
12. Steps involved in activation of the pro-matrix metalloproteinase 9 (progelatinase B)-tissue inhibitor of metalloproteinases-1 complex by 4-aminophenylmercuric acetate and proteinases.
Ogata Y; Itoh Y; Nagase H
J Biol Chem; 1995 Aug; 270(31):18506-11. PubMed ID: 7629179
[TBL] [Abstract][Full Text] [Related]
13. The effects of Candida proteinases on human proMMP-9, TIMP-1 and TIMP-2.
Pärnänen P; Meurman JH; Sorsa T
Mycoses; 2011 Jul; 54(4):325-30. PubMed ID: 20406392
[TBL] [Abstract][Full Text] [Related]
14. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V
Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a truncated recombinant form of human membrane type 3 matrix metalloproteinase.
Shimada T; Nakamura H; Ohuchi E; Fujii Y; Murakami Y; Sato H; Seiki M; Okada Y
Eur J Biochem; 1999 Jun; 262(3):907-14. PubMed ID: 10411655
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9.
Ogata Y; Enghild JJ; Nagase H
J Biol Chem; 1992 Feb; 267(6):3581-4. PubMed ID: 1371271
[TBL] [Abstract][Full Text] [Related]
17. Cellular activation of proMMP-13 by MT1-MMP depends on the C-terminal domain of MMP-13.
Knäuper V; Bailey L; Worley JR; Soloway P; Patterson ML; Murphy G
FEBS Lett; 2002 Dec; 532(1-2):127-30. PubMed ID: 12459476
[TBL] [Abstract][Full Text] [Related]
18. A 17-residue sequence from the matrix metalloproteinase-9 (MMP-9) hemopexin domain binds α4β1 integrin and inhibits MMP-9-induced functions in chronic lymphocytic leukemia B cells.
Ugarte-Berzal E; Bailón E; Amigo-Jiménez I; Vituri CL; del Cerro MH; Terol MJ; Albar JP; Rivas G; García-Marco JA; García-Pardo A
J Biol Chem; 2012 Aug; 287(33):27601-13. PubMed ID: 22730324
[TBL] [Abstract][Full Text] [Related]
19. Expression of human pro-matrix metalloproteinase 3 that lacks the N-terminal 34 residues in Escherichia coli: autoactivation and interaction with tissue inhibitor of metalloproteinase 1 (TIMP-1).
Suzuki K; Kan CC; Hung W; Gehring MR; Brew K; Nagase H
Biol Chem; 1998 Feb; 379(2):185-91. PubMed ID: 9524070
[TBL] [Abstract][Full Text] [Related]
20. HL-60 leukemia cells produce an autocatalytically truncated form of matrix metalloproteinase-9 with impaired sensitivity to inhibition by tissue inhibitors of metalloproteinases.
Ries C; Lottspeich F; Dittmann KH; Petrides PE
Leukemia; 1996 Sep; 10(9):1520-6. PubMed ID: 8751473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
